Incyte
INCY
#1053
Rank
C$32.47 B
Marketcap
C$162.55
Share price
-1.36%
Change (1 day)
76.40%
Change (1 year)

Incyte (INCY) - Total debt

Total debt on the balance sheet as of March 2026 : C$55.42 Million

According to Incyte's latest financial reports the company's total debt is C$55.42 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Incyte - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$55.34 M-11.43%
2024-12-31C$62.48 M23.05%
2023-12-31C$50.78 M-9.73%
2022-12-31C$56.25 M-1.52%
2021-12-31C$57.12 M-5.75%
2020-12-31C$60.6 M-22.95%
2019-12-31C$78.65 M59.82%
2018-12-31C$49.21 M63.1%
2017-12-31C$30.17 M-96.55%
2016-12-31C$0.87 B1.81%
2015-12-31C$0.85 B9.75%
2014-12-31C$0.78 B11.26%
2013-12-31C$0.70 B113.91%
2012-12-31C$0.32 B2.37%
2011-12-31C$0.32 B9.64%
2010-12-31C$0.29 B-37.09%
2009-12-31C$0.46 B-3.2%
2008-12-31C$0.48 B24.91%
2007-12-31C$0.38 B-10.75%
2006-12-31C$0.43 B8.56%
2005-12-31C$0.39 B-12.51%
2004-12-31C$0.45 B109.02%
2003-12-31C$0.21 B-19.9%
2002-12-31C$0.27 B-4.85%
2001-12-31C$0.28 B1.48%
2000-12-31C$0.28 B97447.28%
1999-12-31C$0.28 M-76.55%
1998-12-31C$1.23 M
1996-12-31C$0.13 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
C$66.05 B 119,093.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$89.57 B 161,528.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$60.95 B 109,892.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$80.56 B 145,279.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.63 B 1,046.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C$0.17 B 209.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C$68.72 M 24.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$54.36 M-1.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C$0.29 B 428.19%๐Ÿ‡บ๐Ÿ‡ธ USA